It is with great sadness that the DAIC/ITN team learned of the sudden passing of former Editor Cristen Bolan on June 17. Cristen worked on the brands from 2005-2010, before moving on to other industry related ventures. Our team extends its sincere sympathy to her family and friends.

More information on her memorial service can be found here. 


While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.


June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to welcome a prominent cardiovascular practice in Michigan as a new customer utilizing Positron’s Attrius PET System and services. Positron will install the Attrius in Q4 2024 in accordance with the facility’s timeline. 

June 18, 2024 — Carestream Health recently secured an agreement with Distribuidora Diagnostica Medica SAC (DMD), a leading distr

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has published “Excess Cardiovascular Mortality Among Black Americans 2000-2022: A Report Card,” to highlight the persistent and tragic inequities in cardiovascular care and put in human terms the years of life lost to the Black community because of their higher cardiovascular disease death rates.

June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary Bioadaptor System, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

June 17, 2024 — Medtronic launched the Steerant Aortic Guidewire, tailored to facilitate catheter placement and exchange during diagnostic or interventional procedures in the aorta. The first EVAR case was performed by Dr.

June 17, 2024 — Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro (referred to as CanGaroo during development), has received clearance from the U.S. Food and Drug Administration (FDA).

June 17, 2024 — aycan, a recognized leader in medical imaging, announced today a reseller and technology partnership with AI4MedImaging, a company that specializes in applying artificial intelligence (AI) to medical imaging.

aycan launched its official partnership with AI4MedImaging this week by offering their groundbreaking AI4CMR solution, a Software as a Medical Device (SaMD) that aims to automate the interpretation of cardiac magnetic resonance imaging (CMR) using AI.

Subscribe Now